Skip to content

Solvay Pharmaceuticals

  • Home
  • Company
    • Products
    • Research and development
  • People & careers
    • News
  • Contacts
  • Solvay Useful links
    • Glossary
  • Locations
  • Home
  • Company
    • - Products
    • - Research and development
  • People & careers
    • - News
  • Contacts
  • Solvay Useful links
    • - Glossary
  • Locations

Welcome to Solvay Pharmaceuticals

ACEON®
PHYSIOTENS®
TEVETEN® This information is not intended for US residents
CREON®
DICETEL®
DUSPATAL®
DUPHALAC® This information is not intended for US residents
ROWASA® This information is not intended for US residents
DUPHASTON®
ESTRATEST®
FEMOSTON®
PRESOMEN®
PROMETRIUM®
INFLUVAC®
LUVOX® This information is not intended for US residents
SERC®
International Marketing
Operations
USA
Europe
Japan
Manufacturing
Research and Development
Growth of existing products
Development of new products
Acquisition of new products
Geographical expansion
US
Japan
Worldwide
Strategic alliances in marketing and R&D
Key facts
Key Figures 1998-1999
Recent Achievements
Solvay position on world markets
Growth in sales (1984-1998)
1999 sales breakdown by therapeutic area (in %)
Growth through existing products in 4 therapeutics areas:
Corporate Offices
Regional Offices
Manufacturing Sites
Research Sites
Sales Organizations Worldwide
In Depression and Anxiety
In Schizophrenia
In Cardiovascular Disease
In Irritable Bowel Syndrome
In Delayed Gastric Emptying
In Pancreatic Exocrine Insufficiency
In Hormone Replacement
The Challenge
Solvay Pharmaceuticals’ approach
Targeted Approach

 


Leave a comment Cancel reply

Your email address will not be published. Required fields are marked *

© Solvay S.A • Important information : Solvay Pharmaceuticals  -  Privacy Policy  -  Disclaimer • If you have any comments, please contact the webmaster